<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Quarterly report pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934.
Date of Report: December 4, 2000
Commission file number 000-23266
UroMed Corporation
(Exact name of registrant as specified in its charter)
Massachusetts 04 - 3104185
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
1400 Providence Highway
Norwood, MA 02062
(Address of principal
executive offices)
(781) 762-2080
(Registrant's telephone number, including area code)
<PAGE>
Item 5. Other Events
On December 4, 2000, the registrant issued a press release announcing its
common stock listing on the over-the-counter bulletin board and its delisting
from the Nasdaq SmallCap Market. This will be effective with the opening of
business on December 6, 2000. The ticker symbol for the Company's common stock
will remain URMD.
Item 7. Exhibits
Exhibit Number Description
-------------- ------------
99.1 Press Release issued December 4, 2000 announcing
UroMed Corporation's move to the Over-the-Counter
Bulletin Board ("OTCBB").
<PAGE>
SIGNATURES
Pursuant to requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
UroMed Corporation
Date: December 4, 2000 /s/ Daniel Muscatello
-------------- ----------------------------------
Daniel Muscatello, President and
Chief Executive Officer
Date: December 4, 2000 /s/ Domenic C. Micale
-------------- -----------------------------------
Domenic C. Micale, Vice President
of Finance and Administration, and
Treasurer
